Guru Ownership Trend
Guru Analysis for DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $14.26 M.
Top institutional holders include Leon Cooperman and Private Capital.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $9.88 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 30.3%. Conversely, Leon Cooperman reduced exposure by 38.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for DiaMedica Therapeutics Inc. (DMAC)
Major holders include Leon Cooperman ($16.08 M), Private Capital ($398,000), Cliff Asness ($284,690). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.11 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $9.88 M, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited DMAC. The total reported sell value was $9.95 M.
Yes, 0 managers opened new positions in DMAC, and 1 increased their existing holdings. The total reported buy value was $66,179.58.